It's an unfortunate reality that the majority of strokes occurring in the world are in developing countries, projections over the next 30-years, clearly place increases in incidence and mortality from the burden of stroke in the developing, rather than the developed world. This is particularly true as transition occurs from communicable diseases as the major public health problem to chronic diseases of aging populations.
In other words, developing countries solve one problem and increase the general health of their communities only to be confronted by more chronic health. In this issue we have a number of fascinating contributions from the developing world that highlight the difficulties, which may be encountered in the day-to-day management of stroke patients. Particularly illustrative was the letter from Nepalese neurologist Lekhjung Thapa, whose stark descriptions of the plight of stroke patients in a developing country were reminiscent of those that many of us experienced 30 years ago in the west.
Clearly, in Nepal, there is a need for many to train in stroke medicine to overcome the huge gap in practice standards between the developed and developing world. Similarly, we have a nice piece from Ghana and another from Aceh, in the latter the role of alternative medicines is of interest since these are still used almost universally in developing nations. As a young registrar, I worked briefly in Papua New Guinea, where witch doctors were an accepted part of medical practice, often with questionable results. Even now I know that there are no trained stroke physicians in Papua New Guinea -a sad state of play in many countries.
The WSO is making significant efforts to raise stroke awareness and knowledge in developing countries, including an extensive teaching program through the World Stroke Academy and scholarship programs such as the one held by Lekhjung Thapa in Nepal. More work needs to be done; however, it is gratifying to know that the foundations are gradually being put in place.
This edition also carries an array of articles of interest to all stroke healthcare professionals; ranging from the RIKS stroke story, which really has been the forerunner and template for many national stroke registries worldwide, through to an excellent review of the management of hypertension for primary stroke prevention. Protocols continue and this edition is no exception, we present the preventative antibiotics in stroke study (PASS) rationale, and protocol for a randomized trial, The Secondary Prevention of Small Subcortical Strokes (SPS3) Study. Happy reading!
